PBOX-6

CN(C)C(=O)OC1=C(OC2=CC=CC=C2N3C=CC=C13)C4=C5C=CC=CC5=CC=C4

InChIKey=SOIZAFVNIXAZFQ-UHFFFAOYSA-N

InChI=1S/C25H20N2O3/c1-26(2)25(28)30-24-21-14-8-16-27(21)20-13-5-6-15-22(20)29-23(24)19-12-7-10-17-9-3-4-11-18(17)19/h3-16H,1-2H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment.	2010-07-01	20206141

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:53:25 GMT 2025` Edited by `admin` on `Mon Mar 31 22:53:25 GMT 2025`
Record UNII	IN93MQ497D
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

PBOX-6

Common Name

English

CARBAMIC ACID, DIMETHYL-, 6-(1-NAPHTHALENYL)PYRROLO(2,1-D)(1,5)BENZOXAZEPIN-7-YL ESTER

Preferred Name

English

CARBAMIC ACID, N,N-DIMETHYL-, 6-(1-NAPHTHALENYL)PYRROLO(2,1-D)(1,5)BENZOXAZEPIN-7-YL ESTER

Systematic Name

English

Code System Code Type Description

CAS

290814-68-5

Created by admin on Mon Mar 31 22:53:25 GMT 2025 , Edited by admin on Mon Mar 31 22:53:25 GMT 2025

PRIMARY

FDA UNII

IN93MQ497D

Created by admin on Mon Mar 31 22:53:25 GMT 2025 , Edited by admin on Mon Mar 31 22:53:25 GMT 2025

PRIMARY

PUBCHEM

9865511

Created by admin on Mon Mar 31 22:53:25 GMT 2025 , Edited by admin on Mon Mar 31 22:53:25 GMT 2025

PRIMARY

Related Record Type Details


					IN93MQ497D

PBOX-6

ACTIVE MOIETY